Since 2006, we have awarded over £8.3million to research focused solely on finding a cure for primary bone cancer. To date we have funded 148 research projects and continue to expand our research network, encouraging more researchers to focus their expertise on primary bone cancer.
We recognise that our ability to fund research is limited by our physical and financial resources. Therefore, we aim to maximise the impact of our grants by encouraging research that is likely to win support from larger funding bodies in due course.
We fund research in the UK and encourage national and international collaborative research. We believe there is great value in collaborative research and finding a cure depends on the cooperation of many experts, some of whom will have not worked in bone cancer research to-date.
Download and read our research strategy Accelerating Research to Help More Patients Survive and Thrive.
We place special emphasis on:
- Nurturing the careers of early-stage research staff with an interest in bone cancer research
- Working with research teams to develop their research ideas through an innovative pilot grant scheme
- Supporting proposals which are likely to win support from larger funding bodies
- Encouraging collaboration between research groups
- Encouraging interdisciplinary team work and partnership
- Facilitating access to primary tissue and clinical data
We are dedicated to monitoring and communicating the progression and impact of our research funding to our wide audience of supporters. We hope that this will improve our supporters' understanding of primary bone cancer research and the difference their donations are making.
Our 2022 - 2032 Grant Programme
Our Grant Programme is our public commitment to our supporters and the research community. It is both ambitious and flexible, allowing us to respond to emerging needs over the next 10 years whilst also giving clear transparency to researchers when planning future research.
Calls for grant applications will be announced 18 months in advance of the funding schedule. Additional grants may be added to the programme should funding become available.
Should a new treatment or surgical study be ready for early-stage trials within the set timeline, we will fund a Clinical Trial Grant in 2028. However, should a treatment or surgical study not be at the required stage of development by this time, or if a more urgent priority is identified, this funding will be re-allocated to other grant types within the Grant Programme.
For more details on our Grant Programme, please contact our Research Team.
We receive no regular governmental funding and rely on the support of the general public to continue funding pioneering research.